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Introduction
The Third Report of the National Cholesterol Education
Program Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults (Adult
Treatment Panel III [ATP III]) first provided a working
definition of metabolic syndrome (MetS). MetS repre-
sents a combination of risk factors for cardiovascular
disease (CVD), including atherogenic dyslipidemia,
elevated blood pressure (BP), elevated glucose, a pro-
thrombotic state, and a proinflammatory state [1].
People with MetS are at high risk for diabetes and
coronary heart disease, with an increased mortality rate
from CVD [2,3]. The diagnostic cutoffs for MetS in the
ATP III criteria were subsequently modified in the 2000
World Health Organization Asia Pacific Guideline for
ethnic differences in the risk of diabetes and CVD [4].
The diagnosis of MetS for Taiwanese people was based
on the definition from the Bureau of Health Promotion
in Taiwan in 2005 [5]. The prevalence of MetS varies
according to the definition, age, sex and area. The age-
adjusted prevalence of MetS among adults from the
United States was 23.7% according to ATP III criteria
[6] and the prevalence of MetS was 14.3% (16.1% in
men, 13.8% in women) in Taiwan [7]. The large num-
bers of residents with MetS has become an important
issue with respect to health care policy.
MetS is a progressive disorder which is strongly asso-
ciated with obesity and a sedentary lifestyle. The key 
to treating the abnormalities of MetS involves lifestyle
modification with weight reduction, increase in physical
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activity and a healthy diet. To date, only a few studies
have focused on the effect of lifestyle intervention on
MetS. Furthermore, most studies were based on data
from western countries with quite different lifestyles
and ethnic characteristics compared with the Taiwanese.
The aim of the present study was to investigate the
effects of a hospital-based lifestyle program in women
with MetS from Taiwan.
Materials and Methods
Subjects
A prospective pilot study was conducted to observe the
effects of a hospital-based therapeutic lifestyle program
on women with MetS. Subjects were recruited from the
Department of Internal Medicine and Department of
Obstetrics and Gynecology from the Taiwan Adventist
Hospital and from the community near the hospital. A
questionnaire was conducted for each subject at the
beginning of the study to determine current medical
status. The exclusion criteria included severe systemic
diseases such as coronary heart disease or stroke or
long-term medication for chronic diseases. Subjects who
could not take part in an aerobic exercise program due
to high risk of adverse effects were also excluded. The
present study was approved by the Institutional Review
Board of Taiwan Adventist Hospital.
Collected data included age, medical condition,
anthropometric indices, and biochemical results of 
the subjects. Anthropometric indices, BP and physi-
cal fitness were measured every week. Blood samples
were obtained at the beginning and the end of the 
program.
Anthropometric indices
Body weight was measured to the nearest 0.1 kg while
the subjects were wearing light clothing and height was
measured to the nearest 0.1 cm. Body mass index (BMI)
was then calculated using weight and height measure-
ments. Waist circumference (WC) was measured to
the nearest 0.1 cm at the midway point between the
lowest margin of the rib cage and the iliac crest. BP
was measured on the right arm of the subject using an
automatic BP monitor after 15 minutes rest.
Biochemical tests
After an overnight fasting period of at least 8 hours,
levels of fasting glucose, total-cholesterol, high-density
lipoprotein cholesterol (HDL-C), low-density lipoprotein
cholesterol (LDL-C), alanine aminotransferase, aspartate
aminotransferase, γ-glutamyltransferase and triglyceride
(TG) were measured using commercial kits on an
automated analyzer (Synchron CX9; Beckman Coulter
Co., Fullerton, CA, USA) in the hospital laboratory.
Fasting insulin levels were also determined using
commercial kits on an automated analyzer (Access
Immunoassay System; Beckman Coulter Co.) in the same
laboratory. Homeostasis model assessment for insulin
resistance (HOMA-IR) was used to evaluate insulin re-
sistance as described by Matthews et al [8]. Insulin
resistance was defined as a HOMA-IR ≥ 3.0 [9].
Physical fitness test
The physical fitness of subjects was evaluated at the
beginning of the study at Taiwan Adventist Hospital,
and the parameters measured included cardiovascular
endurance, flexibility, muscular endurance and resting
heart rate. Cardiovascular endurance was measured by
a 3-minute Step-Test. The Sit-and-Reach test was used
to measure flexibility, and the 1-minute sit up test was
used to measure muscular endurance.
Criteria for MetS
The definition for MetS in the present study was in
accordance to the MetS criteria from the Bureau of
Health Promotion in Taiwan. Women who met at least
three of the following five component risk factors were
diagnosed as having MetS: (1) a WC greater than
90 cm; (2) a systolic BP greater than 130 mmHg or 
a diastolic BP greater than 85 mmHg; (3) a fasting 
glucose level greater than 100 mg/dL; (4) a TG level
greater than 150 mg/dL; and (5) a HDL-C level lower
than 50 mg/dL.
The therapeutic lifestyle program was an 8-week
project which included diet control and an aerobic
exercise program. The subjects received a 1-hour lecture
regarding healthy diet every week. Subjects were asked
to record their diet for 2 days every week, including one
weekday and 1 day on the weekend, to evaluate the
content of their diet. A suggested diet was provided by
nutritionists according to body weight, physical condi-
tion, history of disease of the subjects, and after review-
ing the diet diary. The calories were controlled within
1,200–1,800 calories every day according to the for-
mula: total calories = weight (kg) × 40 kcal (for heavy
worker) or 35 kcal (for medium workers) or 30 kcal (for
light workers) − (500–1000) kcal. The suggested diet
contained 55–58% carbohydrates, 14–20% protein and
25–28% fat. It was suggested that subjects use com-
plex instead of simple carbohydrates, using buckeye as
a source of oil, and avoiding foods rich in saturated
fatty acids or containing trans-fatty acids. Subjects also
received a group lecture alternating with aerobic exer-
cise and yoga for 1 hour every week and were asked to
exercise at the gym for at least 180 minutes per week.
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Statistical analysis
Results were expressed in terms of means and standard
deviations for continuous variables and frequencies for
categorical variables. Two-tailed tests of hypotheses
were used to compare the results between the begin-
ning and the end of the study. All statistical analyses
were performed using SPSS software (version 15.0;
SPSS Inc., Chicago, IL, USA). A p value less than 0.05
was considered statistically significant.
Results
From January 2008 to December 2008, 44 women
with MetS completed the therapeutic lifestyle pro-
gram. Table 1 lists the basic characteristics of the 
subjects at the beginning of the study. The mean age
of the subjects was 43.5 (range, 19–61 years). The
mean body weight was 77.4 kg (range, 54.3–122.3 kg).
Mean BMI was 30.2 (range, 21.8–45.6). According 
to the definition specifically for Taiwanese, 8 (18.2%)
were overweight and 32 (72.7%) were obese. The inci-
dence for abnormal WC, BP, fasting glucose level,
HDL-C and TG were 100% (n = 44), 72.7% (n = 32),
47.7% (n = 21), 86.4% (n = 38) and 56.8% (n = 25),
respectively, at the beginning of the program. Only 36
subjects received liver function tests and fasting insulin
measurement.
The results are in Table 2. Mean body weight had
decreased by 3.8% by the end of the program, which
was significantly different. Marked improvement was
found in most components of MetS except HDL-C.
The percentage reduction of WC, systolic BP, diastolic
BP, fasting glucose, HDL-C and TG was 5.3%, 8.5%,
4.7%, 6.9%, 5.6% and 16.3%, respectively.
In addition to the components of MetS, total-
cholesterol, LDL-C and HOMA-IR decreased signifi-
cantly, and a decrease in the fasting insulin concentration
Table 1. Basic characteristics of the women with metabolic 
syndrome at baseline level
Mean ± SD
Age (yr) 43.5 ± 11.3
Body height (cm) 160.3 ± 6.2
Body weight (Kg) 77.4 ± 14.1
BMI (kg/m2) 30.2 ± 5.2
Subjects with metabolic syndrome (n)
3 criteria 23
4 criteria 14
5 criteria 7
SD = standard deviation; BMI = body mass index.
Table 2. Comparison of anthropometric measures, blood pressure, and blood biochemistry at baseline and 8 weeks after 
lifestyle intervention
Baseline 8 wk Difference (%) p
Body weight (kg) (n = 44) 77.4 ± 14.1 74.5 ± 13.2 3.8 < 0.001
BMI (n = 44) 30.2 ± 5.2 29.0 ± 4.9 3.8 < 0.001
WC (cm) (n = 44) 97.0 ± 11.0 91.9 ± 10.4 5.3 < 0.001
Blood pressure (mmHg) (n = 44)
Systolic 137.6 ± 19.1 125.9 ± 16.1 8.5 < 0.001
Diastolic 81.0 ± 11.2 77.2 ± 11.1 4.7 0.006
Insulin sensitivity 
Fasting sugar (mg/dL) (n = 44) 105.0 ± 22.7 97.8 ± 11.3 6.9 0.013
Fasting insulin (μU/mL) (n = 36) 12.5 ± 9.8 10.0 ± 7.6 20.0 0.053
HOMA-IR (n = 36) 3.2 ± 2.6 2.4 ± 1.9 24.4 0.031
Lipid profile (n = 44)
T-Chol (mg/dL) 201.4 ± 38.2 184.3 ± 29.5 8.5 < 0.001
HDL-C (mg/dL) 42.1 ± 9.6 39.7 ± 8.0 5.6 0.001
LDL-C (mg/dL) 128.1 ± 31.2 118.4 ± 25.2 7.6 0.005
TG (mg/dL) 156.0 ± 72.3 130.7 ± 58.3 16.3 0.005
Liver function (n = 36)
AST (U/L) 29.5 ± 12.9 25.5 ± 8.9 13.7 0.006
ALT (U/L) 38.8 ± 30.0 30.1 ± 19.9 22.5 0.001
γ-GT (U/L) 32.4 ± 19.6 25.8 ± 16.0 20.4 0.002
BMI = body mass index; WC = waist circumference; HOMA-IR = homeostasis model assessment for insulin resistance; T-Chol = total cholesterol; HDL-C = high
density lipoprotein cholesterol; LDL-C = low density lipoprotein cholesterol; TG = triglyceride; AST = aspartate aminotransferase; ALT = alanine aminotransferase;
g-GT = g-glutamyltransferase.
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was marginally significant. Marked improvement in
liver function, including aspartate aminotransferase,
alanine aminotransferase, and γ-glutamyltransferase,
was observed in these 36 women.
The Figure shows the percentage of subjects with
abnormal values for each parameter at the baseline
and at the end of the study. Significant reduction in
the percentage of abnormal values was noted in most
parameters except WC and HDL-C. The percentage of
subjects with an abnormal HDL-C concentration had
increased by 5.6% at the end of the study.
Discussion
The present study attempted to investigate the effects
of a hospital-based lifestyle program on women with
MetS in an Asian population. Our findings showed
that up to a 25% reduction of the incidence of MetS was
obtained after an 8-week, short-term program with a
low calorie balanced diet and regular aerobic exercise.
The lifestyle program improved almost all components
of MetS, including WC, BP, fasting glucose and TG.
Significant improvement in insulin sensitivity and liver
function was also observed.
The prevalence of obesity and related comorbidi-
ties has increased rapidly in Taiwan [10]. The prevalence
of obesity increased from 13.2% in the 1993–1996
Nutritional and Health Surveys in Taiwan to around
17% in 2005 [10]. Contributing to this obesity epidemic
may be high fat diets and sedentary lifestyles [11].
Asians appear to be more susceptible to accumulating
excess abdominal fat and developing the health con-
sequences of obesity, even at lower BMIs [4]. Chinese
people with MetS are much more likely to develop
CVD [12].
There are surprisingly few published studies of lifestyle
intervention regarding MetS. Esposito et al demon-
strated dietary intervention with a Mediterranean-style
diet had a 48% net reduction of MetS after 2 years when
compared with the control diet [13]. In the Diabetes
Prevention Program randomized trial, lifestyle interven-
tion was more successful in reducing the incidence of
MetS than treatment with metformin and the placebo
[14]. After a mean follow-up period of 3.2 years, 38% of
the lifestyle intervention group and 18% of the placebo
group no longer had MetS [14]. In a randomized con-
trolled trial involving 375 participants by Bo et al, the
absolute risk reduction for MetS was 31% after a 12
month lifestyle intervention when compared with the
control group [15]. Lifestyle intervention may signifi-
cantly reduce the prevalence of MetS and also reduce
the risk of CVD in the long run [16].
The present study revealed that the lifestyle pro-
gram lowered systolic BP and diastolic BP by 8.5% and
4.7%, respectively. Previous studies have also demon-
strated the effect of lifestyle intervention in lowering
BP [17–20].
Although most of the studies involved diets with
relatively high protein content [17–19], diets with low
protein content were also effective in reducing BP [20].
The present study reveals that a low-calorie diet with
55–58% carbohydrate, 14–20% protein and 25–28%
fat accompanied with regular exercise can effectively
improve hypertension in subjects with MetS.
This lifestyle program results in a significant reduction
of TG concentrations by 16.3% and a 7.6% decrease in
mean HDL-C levels. Previous studies have demonstrated
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Figure. Percentage of subjects with abnormal values for each parameter at the baseline and at the end of the study, *p < 0.05.
MetS = metabolic syndrome; WC = waist circumference; BP = blood pressure; TG = triglyceride; HDL-C = high density lipoprotein
cholesterol; AST = aspartate aminotransferase; ALT = alanine aminotransferase; γ-GT = γ-glutamyltransferase; HOMA-IR =
homeostasis model assessment for insulin resistance.
changes in HDL-C were unremarkable when lifestyle
intervention was greater than 6 months [15,21,22].
However, regular aerobic exercise over 6 months may
significantly increase HDL-C [23]. The decreased HDL-C
concentrations in the present study was probably due
to decreased dietary intake. Additionally, an 8-week exer-
cise program may not be enough to achieve a favor-
able effect on HDL-C levels, with a prolonged period
of intervention required.
Insulin resistance is a result of accumulation of
intracellular lipid metabolites in skeletal muscle and
hepatocytes and plays a key role in the pathophysiol-
ogy of MetS [24]. Previous studies have revealed that 
a lifestyle intervention greater than 6 months might
effectively reduce fasting glucose levels in individuals
with MetS [15,16] while a short-term (10 weeks) inter-
vention could not significantly reduce the fasting glu-
cose level in pre-menopausal women with MetS [25].
The diet control, intensity of exercise and duration of
intervention were all important factors for the results.
The present study revealed a lifestyle intervention, even
one as short as 8 weeks, might effectively reduce fasting
glucose levels and improve insulin sensitivity in Taiwanese
women with MetS. Although the mechanism is not
understood well, exercise might play a key role in effect-
ing insulin concentrations [26,27]. The present study
revealed that even a modest weight reduction of 3.8%
(2.9 kg) may effectively reduce the fasting glucose level
and HOMA-IR by 6.9% and 24.4%, respectively.
Our data also revealed significant improvement in
liver biochemistry and decreases in the percentage of
people with an abnormal liver function after lifestyle in-
tervention. These results confirm our previous report on
subjects with non-alcoholic fatty liver disorders (NAFLD)
[28]. NAFLD has become the most common cause of
abnormal liver function in Taiwan [29]. Although liver
ultrasound or biopsies were not done to prove the
existence of fatty liver in the present study, a previous
study has demonstrated the close association between
MetS and NAFLD [30]. Therefore, the therapeutic
lifestyle program can effectively improve comorbidity
of MetS, such as NAFLD, in addition to components
of MetS.
A major limitation of this study was its lack of con-
trol group. However, it has been revealed that obesity
and metabolic abnormalities could not be improved
without active intervention. The differences between
the beginning and the end of the study were enough to
demonstrate the efficacy of the lifestyle program on the
women with MetS. The second major limitation was
that the follow-up in the present study was limited to 
8 weeks. Therefore, the long term effects of the program
remained to be determined.
In conclusion, this study provides important evidence
that therapeutic lifestyle intervention, even as short as
8 weeks, may effectively correct the metabolic abnor-
malities in women with MetS. The treatment of MetS
in women will become one of the major challenges for
primary physicians as the prevalence of obesity and
MetS increases in Taiwan. Therapeutic lifestyle inter-
vention should be provided as the first line treatment
for MetS. Although more well-designed and large-scale
studies are needed to obtain further evidence, we believe
the present study provides useful information for the
treatment of MetS in Taiwan.
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